Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins

Author： Chae Young Kwang Valsecchi Matias E. Kim Jongoh Bianchi Anabella Lucca Khemasuwan Danai Desai Ajit Tester William

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.29, Iss.9, 2011-10, pp. : 585-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence

By Azoulay Laurent

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 695-703

Springer Publishing Company

Access to resources Recommend Favorite

Diet and risk for breast cancer recurrence and survival

By Saxe G.A.

Breast Cancer Research and Treatment, Vol. 53, Iss. 3, 1999-02 ,pp. : 241-253

Springer Publishing Company

Access to resources Recommend Favorite

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

By Panoff J.

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 899-906

Springer Publishing Company

Access to resources Recommend Favorite

Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study

By Le Ray Isabelle

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 603-609

Springer Publishing Company

Access to resources Recommend Favorite

Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors

By Okamura H.

Breast Cancer Research and Treatment, Vol. 61, Iss. 2, 2000-05 ,pp. : 145-150

Springer Publishing Company

Access to resources Recommend Favorite